B bigemina mostly destroys red blood cells, while the severe types of B bovis cause low blood pressure, widespread inflammation, blood clotting issues, and blockages in small blood vessels.
These parasites are transmitted by specific ticks and are a concern in certain regions like the Middle East, southern Europe, and parts of Africa and Asia.
Babesia bovis infects and replicates within the red blood cells of cattle, leading to anemia, fever, jaundice, and potentially death if not treated promptly.
Babesia bigemina: Another causative agent of bovine babesiosis, Babesia bigemina, is transmitted by the same ticks (Rhipicephalus annulatus and Rhipicephalus microplus) that transmit Babesia bovis.
Supportive treatment, such as anti-inflammatory drugs, corticosteroids, fluid therapy and blood transfusions, is advisable, particularly in valuable animals.
Babesia bovis is generally small, with the parasites in paired form at an obtuse angle to each other while Babesia bigemina is larger, with paired parasites lying almost parallel or at an acute angle to each other.
Dimazine aceturate and Imidocarb dipropionate are used as babesiacides, providing protection from babesiosis for approximately 4 weeks and may also eliminate Babesia bovis and Babesia bigemina from carrier animals.
Babesia bovis infections can cause enlarged and friable spleen, swollen liver with an enlarged gallbladder containing thick granular bile, congested, dark-colored kidneys, generalized anemia and jaundice in postmortem examination.
Live attenuated vaccines have been used successfully in countries such as Argentina, Australia, Brazil, Israel, South Africa, and Uruguay and one vaccination produces adequate immunity for the typical productive lifespan of animals.